Sex: M
Vaccine: COVID19
Symptoms: Illness, Malaise, Post-acute COVID-19 syndrome, Spirometry
Clinical narrative: developed post covid syndrome; Costochondritis; got sick; chest wall inflammation covid symptoms; breathing is totally compromised; physically messed up; developed post covid syndrome/ exposed to another child who was unvaccinated and her one grandson got sick; grandson who had covid/ in sept one of the child was exposed to another child who was unvaccinated/ developed post covid syndrome; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team.  A 16 year-old male patient received bnt162b2 (BNT162B2), administration date Apr2021 (Batch/Lot number: unknown) as dose number unknown, single for covid-19 immunisation. Relevant medical history included: "asthma" (unspecified if ongoing), notes: uses inhaler, nebulizer etc. for asthma. Family history included: "COPD" (unspecified if ongoing), notes: grandmother. The patient's concomitant medications were not reported.  The following information was reported: DRUG INEFFECTIVE (medically significant) with onset Sep2021, outcome "unknown", described as "developed post covid syndrome/ exposed to another child who was unvaccinated and her one grandson got sick"; COVID-19 (medically significant) with onset Sep2021, outcome "unknown", described as "grandson who had covid/ in sept one of the child was exposed to another child who was unvaccinated/ developed post covid syndrome"; POST-ACUTE COVID-19 SYNDROME (non-serious), outcome "unknown", described as "developed post covid syndrome"; COSTOCHONDRITIS (non-serious), outcome "unknown", described as "Costochondritis"; ILLNESS (non-serious), outcome "unknown", described as "got sick"; CHEST DISCOMFORT (non-serious), outcome "unknown", described as "chest wall inflammation covid symptoms"; DYSPNOEA (non-serious), outcome "unknown", described as "breathing is totally compromised"; MALAISE (non-serious), outcome "unknown", described as "physically messed up". The patient underwent the following laboratory tests and procedures: spirometry: did very poorly. Additional information: Caller stated she has identical twins grandsons who were vaccinated in Apr and in sep one of the child was exposed to another child who was unvaccinated and her one grandson got sick but the other grandchild did not. The grandson who was sick developed post covid syndrome, "Costochondritis" chest wall inflammation covid symptoms, both boys will be 17 on Monday. He has been out of school for some time. they have Preexisting conditions uses inhaler, nebulizer etc. for asthma. She stated their doctor is ok with them getting the booster, but the vaccination site refuses as they are not 18 yet. She thinks they are immunocompromised because of the pre-existing health condition. She stated the grandson who had covid did very poorly on the spirometer test but other one was good. Caller wanted to know about the getting booster for her grandsons and herself. He stated he needs booster dose to stay out of the hospital. She stated he needs to speak to a lawyer to help get her grandson get the booster as this is discrimination against the age and health status. He desperately needs the booster, his breathing is totally compromised, he is unable to do things that he wants to do, he is physically messed up. She stated your website says they can get. Caller stated one guy was vaccinated and received booster dose, but he still got the omicron covid variant, he was not hospitalized. She stated she and her son got the 2 doses of the vaccine and she wanted to know about the booster dose. She stated she has COPD. She stated FDA may approve the booster for 16-17 years old when/if some kids die. This is what it will take them to approve the booster dose.  The lot number for bnt162b2 was not provided and will be requested during follow up.